Corporate Governance

^{5th session
of
7th meeting}

• Ratified the regulations for the issuance of the first employee stock option in 2020
• Revised the Rules of Procedure for the Board of Directors
• Revised the Rules of Procedure for the Shareholders’ Meeting
• Revised the Director Selection Procedure
• Formulated the Code of Integrity
• Formulated the Code of Ethical Conduct for Directors and Managers
• Formulated the Procedures for Integrity Management and Guidelines for Conduct
• Approved liability insurance for directors and important employees
• Revised the regulations for the management of manager remuneration
• Issued the first employee stock option certificate in 2020
• The 2021 CPA audit fee
• By-election of independent directors and shareholder nomination related matters
• Review of independent director candidates nominated by the Board of Directors
• Lifting the prohibition on non-competition for new independent directors
• Convened the extraordinary general meeting in 2021

^{6th session
of
7th meeting}

• The 2020 business report and financial statement
• The 2020 loss make‑up proposal
• The 2020 statement of internal control
• The company’s corporate social responsibility code of practice
• Revised the company’s Information Security Management Regulations, and the computerized Information System Processing Recycling System
• Abolished the company’s Director and Supervisor Election Regulations
• Formulated the work plan for the company to conduct its own IFIR report
• Application for OTC listing
• To conduct stock underwriting for a cash capital increase prior to initial OTC listing,with existing shareholders waiving their preemptive rights
• To convent the 2021 regular shareholders’ meeting and the company accept shareholders to submit proposals to be discussed at the meeting.

^{7th session
of
7th meeting}

• Appointment of a new independent director as a member of the Company’s remuneration committee

^{8th session
of
7th meeting}

• Formulated the company’s Corporate Governance Best Practice Principles
• Formulated the company’s Regulations for the Performance Evaluation of the Board of Directors
• Revised some of the company’s internal control-related management regulations and procedures
• Application for OTC listing
• Depository plan for the initial OTC listing and OTC listing over-allotment agreement
• Financial statements for the first quarter of 2021
• The company’s statement of internal control from April 1, 2020 to March 31, 2021
• Investment and purchase of bonds or government bonds with conditions of repurchase and sell-back
• Assessment report of foreign agents

^{9th session
of
7th meeting}

• Changed the date and place of the 2021 shareholders meeting

^{10th session
of
7th meeting}

• 2021 second quarter financial report
• Investment and purchase of bonds or government bonds with conditions of repurchase and sell-back
• Change of the Company’s Acting Spokesperson and manager
• Assessment report of foreign agents

1^st session
of
7^th meeting

• The election of the Chairman of the Board
• Appointment of members of the Remuneration Committee

2^nd session
of
7^th meeting

• Financial report for the first half of 2020
• Formulated the Management Procedures for Handling Internal Material Information and Preventing Insider Trading
• Formulated the Operational Procedures for Applications for Halt and Resumption of TPEx Trading of its Stock
• Formulated the Operating Procedures for Reporting Information for Newly Employed (Dismissed) Insiders
• Formulated the Remuneration Management Regulations for Directors and Functional Committee Members and the Remuneration Management Regulations for Managers
• Determined the remuneration for the current Chairman of the Board
• Determined the professional practice fees of the current directors
• Determined the remuneration and the professional practice fees of the current independent directors
• The monthly salary standard and structure for managers

3^rd session
of
7^th meeting

• Conducted the 2^nd cash capital increase and the issuance of new shares in 2020
• Formulated the company’s Cash Capital Increase and Employee Stock Option Regulations
• 2^nd employee stock option for cash capital increase in 2020- managers allowed to subscribe shares
• Evaluation report of agents in China

4^th session
of
7^th meeting

• The company’s 2021 annual audit plan
• Revised the company’s Scope of Duties of Independent Directors
• Revised the company’s Organizational Regulations for the Remuneration Committee
• Revised the company’s Organizational Regulations for the Audit Committee
• Formulated the company’s Management Regulations for Laws and Regulations compliance
• Formulated the Regulations for the Issuance of the 1^st Employee Stock Option certificate and the Subscription of Shares in 2020
• Overdue accounts that are not loaned to others
• Ratified the change of the company’s agent spokesperson
• 2020 annual manager salary adjustment
• 2020 annual manager year-end and performance bonuses
• The year-end bonus of the Chairman of the Company
• 2021 annual budget and 2021 sound business plan